WASHINGTON, DC —
The first prescription pill to treat low sexual desire in women was finally approved by the U.S. Food and Drug Administration on Tuesday.
The little pink pill will be sold under the brand name Addyi and manufactured by Sprout Pharmaceuticals, a privately held company. It will only be available through certified and specially trained healthcare professionals and pharmacies due to its potentially dangerous side effects.
Addyi, whose generic name is flibanserin, is designed to help women get their groove back. The pill is designed for premenopausal women who suffer from hypoactive sexual desire disorder (HSDD).
The FDA rejected flibanserin twice in the past, but finally caved after a heavy lobbying campaign by Sprout and women's groups.
Women who took Addyi in a clinical study had an increase of about one orgasm a month, so that means a whopping 12 extra orgasms a year. Only problem is you need to take Addyi every day.
Addyi can cause low blood pressure, fainting, nausea, dizziness, sleepiness and shouldn't be taken with booze, but otherwise it's completely safe.